18 December 2020 – Takis added to the EU Malaria Fund portfolio
Takis has been added to the European Malaria Fund portfolio.
The EU Malaria Fund is a public-private partnership between the European Union, international organizations, corporations and organized civil society, providing a new funding tool to address market failures in infectious diseases with a significant relevance to public health globally.
Every two minutes a child under the age of five dies of malaria. We will make our knowledge and expertise available in genetic vaccination platforms to help combat this complex disease. This is an exciting new challenge that we can't wait to get started.
Malaria-eVax is a multistage targeted vaccine against malaria.
Read more: Control Malaria – EU Malaria Fund